4D Molecular Therapeutics, Inc. Financial Ratios — FDMT

Profitability (USD)

	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Return on Common Equity (%)	- -	- -	- -	- -	-24.78	-39.06	-37.4	-39.31	-27.57
Return on Assets (%)	- -	-15.37	-63.54	-32.72	-22.22	-34.94	-33.52	-35.74	-24.86
Return on Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -
Return on Invested Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -
Gross Margin (%)	100	100	100	100	100	100	100	100	100
EBITDA Margin (%)	-183.87	-68.66	-638.75	-405.68	-378.72	-3,392.52	-516.9	-489,556.76	-178.29
Operating Margin (%)	-194.68	-73.6	-653.12	-416.28	-395.46	-3,516.52	-544.65	-507,678.38	-187.24
Incremental Operating Margin (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -
Pretax Margin (%)	-193.83	-67.59	-705.78	-416.49	-395.37	-3,435.41	-486.59	-434,778.38	-164.43
Profit Margin (%)	-193.83	-67.59	-705.78	-416.49	-395.37	-3,435.41	-486.59	-434,778.38	-164.43
Net Income to Common Margin (%)	-193.83	-67.59	-705.78	-416.49	-395.37	-3,435.41	-486.59	-434,778.38	-164.43
Effective Tax Rate (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -
Dvd Payout Ratio (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -
Sustainable Growth Rate (%)	- -	- -	- -	- -	-24.78	-39.06	-37.4	-39.31	-27.57

Credit (USD)

Credit Ratios API ChatGPT

	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Total Debt	- -	- -	- -	- -	16	16	15	25	21
ST Debt	- -	- -	- -	- -	1	3	3	6	6
LT Debt	- -	- -	- -	- -	15	13	12	19	16
Total Debt/EBITDA	- -	- -	- -	- -	-0.24	-0.15	-0.14	-0.14	-0.14
Net Debt/EBITDA	2.24	9.46	1.11	5.01	2.24	0.49	2.33	0.82	0.4
Total Debt/EBIT	- -	- -	- -	- -	-0.23	-0.15	-0.13	-0.13	-0.13
Net Debt/EBIT	2.12	8.82	1.09	4.88	2.14	0.48	2.21	0.8	0.38
EBITDA to Interest Expense	- -	- -	- -	- -	- -	- -	- -	- -	- -
EBITDA-CapEx/Interest Expense	- -	- -	- -	- -	- -	- -	- -	- -	- -
EBIT to Interest Expense	- -	- -	- -	- -	- -	- -	- -	- -	- -
Interest Expense	- -	- -	- -	- -	- -	- -	- -	- -	- -
Common Equity/Total Assets	-71.71	-28.45	-125.3	88.92	90.27	88.35	90.57	91.12	89.23
Long-Term Debt/Equity (%)	- -	- -	- -	- -	4.77	5.82	3.74	3.71	3.13
Long-Term Debt/Capital (%)	- -	- -	- -	- -	4.53	5.44	3.57	3.54	3
Long-Term Debt/Total Assets (%)	- -	- -	- -	- -	4.3	5.14	3.39	3.39	2.79
Total Debt/Equity (%)	- -	- -	- -	- -	5.15	6.97	4.77	4.82	4.23
Total Debt/Capital (%)	- -	- -	- -	- -	4.9	6.52	4.55	4.6	4.06
Total Debt/Total Assets (%)	- -	- -	- -	- -	4.65	6.16	4.32	4.39	3.78
Net Debt to Equity	121.75	332.62	68.04	-107.93	-47.95	-22.63	-80.92	-29.25	-11.91
Net Debt/Capital (%)	54.9	76.89	40.49	1,360.57	-83.81	-26.83	-339.42	-38.7	-12.9
EBITDA	-11	-10	-45	-55	-68	-106	-107	-181	-152
EBITDA-CapEx	-11	-10	-48	-56	-77	-118	-110	-185	-152
Operating Income (Loss)	-11	-10	-46	-57	-71	-110	-113	-188	-160

Liquidity (USD)

Liquidity Ratios API ChatGPT

	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Cash Ratio	4.04	11.39	3.83	16.53	15.17	13.58	15.21	14.58	9.15
Current Ratio	4.15	11.68	4.05	16.88	15.69	14.02	15.65	14.92	9.39
Quick Ratio	4.09	11.53	3.91	16.62	15.17	13.58	15.21	14.58	9.15
CFO/Avg Current Liab	- -	-2.33	-3.49	-3.43	-4.18	-5.41	-4.37	-5.6	-2.98
Common Equity/Total Assets	-71.71	-28.45	-125.3	88.92	90.27	88.35	90.57	91.12	89.23
Long-Term Debt/Equity (%)	- -	- -	- -	- -	4.77	5.82	3.74	3.71	3.13
Long-Term Debt/Capital (%)	- -	- -	- -	- -	4.53	5.44	3.57	3.54	3
Long-Term Debt/Total Assets (%)	- -	- -	- -	- -	4.3	5.14	3.39	3.39	2.79
Total Debt/Equity (%)	- -	- -	- -	- -	5.15	6.97	4.77	4.82	4.23
Total Debt/Capital (%)	- -	- -	- -	- -	4.9	6.52	4.55	4.6	4.06
Total Debt/Total Assets (%)	- -	- -	- -	- -	4.65	6.16	4.32	4.39	3.78
CFO/Total Liabilities	17.56	-13.05	-27.98	-159.37	-201.09	-284.13	-236.39	-270.37	-178.69
CFO/CapEx	14.38	-39.26	-11.46	-50.91	-7.59	-7.51	-27.35	-35.55	-203.51
Altman's Z-Score	-1.38	0.42	-3.55	20.62	11.72	12.13	14.57	1.4	2.48

Working Capital (USD)

Working Capital Ratios API ChatGPT

	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Accounts Receivable Turnover	- -	19.56	6.65	11.05	23.53	133.15	- -	- -	- -
Days Sales Outstanding	- -	18.66	54.91	33.04	15.51	2.74	- -	- -	- -
Inventory Turnover	- -	- -	- -	- -	- -	- -	- -	- -	- -
Days Inventory Outstanding	- -	- -	- -	- -	- -	- -	- -	- -	- -
Accounts Payable Turnover	- -	- -	- -	- -	- -	- -	- -	- -	- -
Accounts Payable Turnover Days	- -	- -	- -	- -	- -	- -	- -	- -	- -
Cash Conversion Cycle	- -	- -	- -	- -	- -	- -	- -	- -	- -
Inventory to Cash Days	- -	- -	- -	- -	- -	- -	- -	- -	- -
Inventories	- -	- -	- -	- -	- -	- -	- -	- -	- -
Raw Materials	- -	- -	- -	- -	- -	- -	- -	- -	- -
Work In Process	- -	- -	- -	- -	- -	- -	- -	- -	- -
Finished Goods	- -	- -	- -	- -	- -	- -	- -	- -	- -
Other Inventory	- -	- -	- -	- -	- -	- -	- -	- -	- -

Enterprise Value (USD)

Enterprise Value API ChatGPT

	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Market Capitalization	- -	- -	- -	1,106	707	725	873	255	432
- Cash & Cash Equivalents	24	92	50	277	153	52	249	149	60
+ Preferred Equity and Hybrid Capital	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Minority/Non Controlling Interest	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Total Debt	- -	- -	- -	- -	16	16	15	25	21
Enterprise Value	-24	-92	-50	829	476	527	599	-145	51
Total Capital	-20	-28	-73	256	336	247	322	535	527
Total Debt/Capital (%)	- -	- -	- -	- -	4.9	6.52	4.55	4.6	4.06
Total Debt / EV	- -	- -	- -	- -	0.03	0.03	0.02	-0.17	0.42
EV/Sales	- -	- -	- -	60.92	26.37	168.49	28.91	- -	0.6
EV/EBITDA	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/EBIT	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/Cash Flow to Firm	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/Free Cash Flow to Firm	- -	- -	- -	- -	- -	- -	- -	- -	- -
Diluted Market Cap	- -	- -	- -	267	608	719	793	300	434
Diluted Enterprise Value	-24	-92	-50	-10	472	682	558	176	396
EV per Share	- -	- -	- -	31.08	14.76	16.16	13.91	- -	0.88
TTM Sales	6	14	7	14	18	3	21	- -	85
TTM EBITDA	-11	-10	-45	-55	-68	-106	-107	-181	-152
TTM Operating Income	-11	-10	-46	-57	-71	-110	-113	-188	-160
TTM Cash Flow to Firm	8	-16	-37	-51	-69	-87	-76	-135	-109
TTM Free Cash Flow to Firm	9	-16	-34	-50	-60	-75	-73	-131	-109

Multiples (USD)

Valuation Multiples API ChatGPT

	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Price/Free Cash Flow	- -	- -	- -	-5.34	-10.14	-9.56	-10.86	-2.3	-4
EV/EBIT	- -	- -	- -	- -	- -	- -	- -	- -	- -
Enterprise Value	-24	-92	-50	829	476	527	599	-145	51
Low Price	- -	- -	- -	36.1	18.57	5.32	9.44	5.22	2.24
EV/Sales	- -	- -	- -	60.92	26.37	168.49	28.91	- -	0.6
EV/EBITDA	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Earnings	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Earnings Average	- -	- -	- -	-4.68	-12.38	-3.75	-6.57	-6.26	-2.53
Price/Earnings High	- -	- -	- -	-5.56	-21.43	-7.97	-9.35	-12.16	-5.1
Price/Earnings Low	- -	- -	- -	-4.09	-7.22	-1.6	-3.66	-1.75	-0.93
Price/Book Value	- -	- -	- -	4.31	2.22	3.13	2.84	0.5	0.85
Price/Book Value Average	- -	- -	- -	4.3	3.22	1.76	2.37	1.67	0.7
Price/Book Value High	- -	- -	- -	5.11	5.57	3.74	3.37	3.25	1.41
Price/Book Value Low	- -	- -	- -	3.76	1.88	0.75	1.32	0.47	0.26
Price/Tangible Book Value	- -	- -	- -	4.31	2.22	3.13	2.84	0.5	0.85
Price/Tangible Book Value Average	- -	- -	- -	4.3	3.22	1.76	2.37	1.67	0.7
Price/Tangible Book Value High	- -	- -	- -	5.11	5.57	3.74	3.37	3.25	1.41
Price/Tangible Book Value Low	- -	- -	- -	3.76	1.88	0.75	1.32	0.47	0.26
Price/Sales	- -	- -	- -	19.58	33.73	229.63	38.26	8,120.72	5.1
Price/Sales Average	- -	- -	- -	19.5	48.95	128.89	31.95	27,197.62	4.17
Price/Sales High	- -	- -	- -	23.18	84.72	273.88	45.51	52,850.29	8.39
Price/Sales Low	- -	- -	- -	17.05	28.55	55	17.83	7,610.44	1.52
Price/Cash Flow	- -	- -	- -	-5.24	-8.8	-8.29	-10.46	-2.23	-3.98
Price/Cash Flow Average	- -	- -	- -	-5.21	-12.77	-4.65	-8.73	-7.48	-3.26
Price/Cash Flow High	- -	- -	- -	-6.2	-22.11	-9.89	-12.44	-14.53	-6.55
Price/Cash Flow Low	- -	- -	- -	-4.56	-7.45	-1.99	-4.87	-2.09	-1.19
Price/Free Cash Flow Average	- -	- -	- -	-5.32	-14.71	-5.37	-9.07	-7.69	-3.27
Price/Free Cash Flow High	- -	- -	- -	-6.32	-25.46	-11.4	-12.91	-14.95	-6.59
Price/Free Cash Flow Low	- -	- -	- -	-4.65	-8.58	-2.29	-5.06	-2.15	-1.2
EV/Sales Average	- -	- -	- -	60.59	49.31	118.41	23.85	19,717.53	3.69
EV/Sales High	- -	- -	- -	75.84	90.88	264.64	38.78	41,494.61	7.89
EV/Sales Low	- -	- -	- -	50.43	25.6	43.89	8.31	3,089.58	1.06
EV/EBITDA Average	2.24	9.46	1.11	-14.93	-13.02	-3.49	-4.61	-4.03	-2.07
EV/EBITDA High	2.24	9.46	1.11	-18.69	-24	-7.8	-7.5	-8.48	-4.42
EV/EBITDA Low	2.24	9.46	1.11	-12.43	-6.76	-1.29	-1.61	-0.63	-0.59
EV/EBIT Average	2.12	8.82	1.09	-14.55	-12.47	-3.37	-4.38	-3.88	-1.97
EV/EBIT High	2.12	8.82	1.09	-18.22	-22.98	-7.53	-7.12	-8.17	-4.21
EV/EBIT Low	2.12	8.82	1.09	-12.12	-6.47	-1.25	-1.53	-0.61	-0.57
Last Price	- -	- -	- -	41.45	21.94	22.21	20.26	5.57	7.5
High Price	- -	- -	- -	49.06	55.11	26.49	24.1	36.25	12.34
Enterprise Value Average	-24	-92	-50	825	889	371	494	730	314
Enterprise Value High	-24	-92	-50	1,032	1,639	828	804	1,535	672
Enterprise Value Low	-24	-92	-50	686	462	137	172	114	90

Shares Outstanding	22	22	22	27	32	33	43	46	58
Diluted Weighted Avg Shares	15	13	15	6	28	32	39	54	58
Basic Weighted Avg Shares	15	13	15	6	28	32	39	54	58
Revenue per Share	0.39	1.13	0.47	2.12	0.65	0.1	0.53	- -	1.47
EBITDA per Share	-0.72	-0.78	-3.01	-8.59	-2.46	-3.28	-2.74	-3.36	-2.62
Operating Income per Share	-0.76	-0.83	-3.08	-8.81	-2.57	-3.4	-2.88	-3.48	-2.75
Basic EPS, GAAP	-0.76	-0.76	-3.32	-8.82	-2.57	-3.32	-2.58	-2.98	-2.42
Basic EPS from Cont Ops	-0.76	-0.76	-3.32	-8.82	-2.57	-3.32	-2.58	-2.98	-2.42
Diluted EPS, GAAP	-0.76	-0.76	-3.32	-8.82	-2.57	-3.32	-2.58	-2.98	-2.42
Diluted EPS from Cont Ops	-0.76	-0.76	-3.32	-8.82	-2.57	-3.32	-2.58	-2.98	-2.42
Dividend per Share	- -	- -	- -	- -	- -	- -	- -	- -	- -
Cash Flow per Share	0.56	-1.3	-2.47	-7.92	-2.49	-2.68	-1.94	-2.49	-1.88
Free Cash Flow per Basic Share	0.52	-1.33	-2.69	-8.07	-2.82	-3.04	-2.01	-2.57	-1.89
Cash & Equivalents per Share	1.1	4.25	2.3	10.37	7.69	6.55	6.69	9.28	6.99
Book Value per Share	-0.91	-1.28	-3.38	9.61	9.9	7.09	7.15	11.15	8.78
Tangible Book Value per Share	-0.91	-1.28	-3.38	9.61	9.9	7.09	7.15	11.15	8.78

4D Molecular Therapeutics, Inc.

Profitability (USD)

Credit (USD)

Liquidity (USD)

Working Capital (USD)

Enterprise Value (USD)

Multiples (USD)

Per Share Data Items (USD)